A phase II study of a gene-modified vaccinia virus expressing MUC1 and IL-2 (TG1031) in patients with metastatic breast cancer

ICRF Breast Canc Biol Grp, E Windmill, R B Acres, J Taylor-Papadimitriou, D W Miles

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	25 - 25
Number of pages	1
Journal	BJC: British Journal of Cancer
Volume	85
Publication status	Published - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{8352b34e3f384bf5852a9f3125b43c22,

title = "A phase II study of a gene-modified vaccinia virus expressing MUC1 and IL-2 (TG1031) in patients with metastatic breast cancer",

author = "{ICRF Breast Canc Biol Grp} and E Windmill and Acres, {R B} and J Taylor-Papadimitriou and Miles, {D W}",

year = "2001",

language = "English",

volume = "85",

pages = "25 -- 25",

journal = "BJC: British Journal of Cancer",

issn = "1532-1827",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - A phase II study of a gene-modified vaccinia virus expressing MUC1 and IL-2 (TG1031) in patients with metastatic breast cancer

AU - ICRF Breast Canc Biol Grp

AU - Windmill, E

AU - Acres, R B

AU - Taylor-Papadimitriou, J

AU - Miles, D W

PY - 2001

Y1 - 2001

M3 - Meeting abstract

SN - 1532-1827

VL - 85

SP - 25

EP - 25

JO - BJC: British Journal of Cancer

JF - BJC: British Journal of Cancer

ER -